DOD Rebounds 5%, Asserting a Constant Growth and No Selloff from Major Shareholders
Ms. Supamas, Chairman of Executive Committee of DOD, has denied over several rumors that causes DOD's share price to plunge 20% in a month, asserting that there is no selloff from the company's major shareholder while the business has a constant growth.
15 มี.ค. 2562

Several rumors have been circulating in the past few days regarding DOD Biotech Public Company Limited (DOD), which caused the share price of DOD to plunge dramatically from ฿12.80/share on February 13 to ฿10.00/share on March 13, decreased by 21%.
 
Ms. Supamas Isarabhakdi, Chairman of Executive Committee of DOD, has clarified through the broadcast with Kaohoon on Facebook Live, YouTube Live and FM 102 on the rumor of a selloff from major shareholders DOD, which is the opposite of what it is since every major shareholder of DOD still hold on to the share.
As for the rumour regarding a loss of revenue in 1Q19, Ms. Supamas asserts that DOD’s revenue has a constant growth, and currently holding five deals which has much higher value than the previous deal that the company had made with PCCA Laboratory Co., Ltd. (PCCA) worth THB 297 million to start producing OEM cosmetic and skincare products.
Moreover, Ms. Supamas also states that DOD’s directors did not make a selloff in order to turn to politic as rumored.
 
DOD’s share price closed at 10.50/share in the morning session, gained 0.50/share or 5% with ฿51 million in value.
 